Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF)
OTCMKTS · Delayed Price · Currency is USD
8.56
+1.06 (14.13%)
At close: May 22, 2025

RAJAF Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-0.230.75-0.72-0.49-0.02
Depreciation & Amortization
0.510.140.0800.04
Loss (Gain) From Sale of Assets
-0----
Other Operating Activities
0.02-0.550.30.37-
Change in Accounts Receivable
0-0--0.01-0
Change in Inventory
-0.12-0.19---1
Change in Accounts Payable
0.10.18--0.75
Change in Income Taxes
00.02---
Change in Other Net Operating Assets
0.02-0.03-0.06-0.020.04
Operating Cash Flow
0.310.36-0.32-0.37-0.2
Operating Cash Flow Growth
-13.26%----
Capital Expenditures
-0.35-0.32--0.1-1.67
Sale of Property, Plant & Equipment
0.04----
Other Investing Activities
--0-0-0.01-0.58
Investing Cash Flow
-0.31-0.32-0-0.11-2.25
Short-Term Debt Issued
-0.010.310.18-
Total Debt Issued
-0.010.310.182.47
Short-Term Debt Repaid
----0.08-
Total Debt Repaid
----0.08-0.03
Net Debt Issued (Repaid)
-0.010.310.12.45
Issuance of Common Stock
---0.23-
Other Financing Activities
--0.05-0.060.25-
Financing Cash Flow
--0.030.250.572.45
Foreign Exchange Rate Adjustments
0.01-0-0.0100
Net Cash Flow
0.010.01-0.080.10
Free Cash Flow
-0.040.04-0.32-0.47-1.86
Free Cash Flow Margin
-2.97%4.56%-602.91%--922.13%
Free Cash Flow Per Share
---0.00-0.01-0.02
Cash Income Tax Paid
----0
Levered Free Cash Flow
1.360.541.53-0.08-
Unlevered Free Cash Flow
1.370.561.53-0.08-
Change in Net Working Capital
-1.32-0.6-1.7-0.09-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.